Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.51 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.51 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.38 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.37 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.37 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7972821 | 1.00 | AKR1C3 (0.51) | AKR1C3AKR1C1ALOX5KDM4ENPC1 | |
| SCHEMBL7973212 | 1.00 | AKR1C3 (0.51) | AKR1C3AKR1C1ALOX5KDM4ENPC1 | |
| SCHEMBL7972824 | 1.00 | AKR1C3 (0.51) | AKR1C3AKR1C1ALOX5KDM4ENPC1 | |
| SCHEMBL7973213 | 1.00 | AKR1C3 (0.51) | AKR1C3AKR1C1ALOX5KDM4ENPC1 | |
| SCHEMBL7969772 | 0.92 | ALOX5 (0.47) | AKR1C3AKR1C1ALOX5KDM4E | |
| SCHEMBL9195805 | 0.92 | ALOX5 (0.47) | AKR1C3AKR1C1ALOX5KDM4E | |
| SCHEMBL7969770 | 0.92 | ALOX5 (0.47) | AKR1C3AKR1C1ALOX5KDM4E | |
| SCHEMBL7969771 | 0.92 | ALOX5 (0.47) | AKR1C3AKR1C1ALOX5KDM4E | |
| SCHEMBL9195806 | 0.92 | ALOX5 (0.47) | AKR1C3AKR1C1ALOX5KDM4E | |
| SCHEMBL7969789 | 0.90 | AKR1C3 (0.46) | AKR1C3AKR1C1ALOX5KDM4ENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6291520-B1 | INHIBIT THE ENZYME LIPOXYGENASE; TREATMENT OR ALLEVIATION OF INFLAMMATORY DISEASES, ALLERGIC CONDITIONS AND CARDIOVASCULAR DISEASES | PFIZER | 2001-09-18 | — | — | US | claimed |
| US-6291520-B1 | INHIBIT THE ENZYME LIPOXYGENASE; TREATMENT OR ALLEVIATION OF INFLAMMATORY DISEASES, ALLERGIC CONDITIONS AND CARDIOVASCULAR DISEASES | PFIZER | 2001-09-18 | — | — | US | disclosed |
| EP-0559743-B1 | NOVEL HYDROXAMIC ACID AND N-HYDROXYUREA DERIVATIVES AND THEIR USE | PFIZER (US) | 1995-03-08 | — | — | EP | disclosed |
| EP-0559743-A1 | NOVEL HYDROXAMIC ACID AND N-HYDROXYUREA DERIVATIVES AND THEIR USE. | PFIZER HOSPITAL PROD (US) | 1993-09-15 | — | — | EP | disclosed |
| WO-1992009566-A1 | NOVEL HYDROXAMIC ACID AND N-HYDROXYUREA DERIVATIVES AND THEIR USE | PFIZER INC. (US) | 1992-06-11 | — | — | WO | disclosed |